FTC sues significant pharmacy gain managers in excess of insulin charges The agency introduced motion against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record price of life-saving insulin medication. This program aligns with Those people initiatives, the ONC said. The industry https://ayahealthcareaddress74073.pages10.com/the-smart-trick-of-healthcare-news-that-nobody-is-discussing-66216317